Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Giralt

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
Bone Marrow Transplantation|September 11, 2001
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I studyF Ravandi, H Kantarjian, A Cohen, et al.
Bone Marrow Transplantation|March 1, 1997
Allogeneic blood stem cell transplantation in advanced hematologic cancersD Przepiorka, P Anderlini, C Ippoliti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphomaC Hosing, M Munsell, S Yazji, et al.
Bone Marrow Transplantation|June 27, 2006
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemiaP Kebriaei, R M Saliba, C Ma, et al.
Bone Marrow Transplantation|July 10, 2008
Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?G J Ruiz-Argüelles, L C Tarin-Arzaga, M L Gonzalez-Carrillo, et al.
Bone Marrow Transplantation|July 8, 2014
Donor-recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selectionP B Dahi, D M Ponce, S Devlin, et al.
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancyI F Khouri, M S Lee, J Romaguera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphomaI F Khouri, J Romaguera, H Kantarjian, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
Bone Marrow Transplantation|September 11, 2001
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I studyF Ravandi, H Kantarjian, A Cohen, et al.
Bone Marrow Transplantation|March 1, 1997
Allogeneic blood stem cell transplantation in advanced hematologic cancersD Przepiorka, P Anderlini, C Ippoliti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphomaC Hosing, M Munsell, S Yazji, et al.
Bone Marrow Transplantation|June 27, 2006
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemiaP Kebriaei, R M Saliba, C Ma, et al.
Bone Marrow Transplantation|July 10, 2008
Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?G J Ruiz-Argüelles, L C Tarin-Arzaga, M L Gonzalez-Carrillo, et al.
Bone Marrow Transplantation|July 8, 2014
Donor-recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selectionP B Dahi, D M Ponce, S Devlin, et al.
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancyI F Khouri, M S Lee, J Romaguera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphomaI F Khouri, J Romaguera, H Kantarjian, et al.
Pageof 18